Table 3.
Included studies.
| Study | Study type and design | Country | Patients with PT (n) | Surgery types | Median follow-up in months (range) | Mean PT size in cm (range) | Mean age in years (range) | |
| Borderline | Malignant | |||||||
| Mitus 201915 | Single-centre, retrospective cohort | Poland | 40 | 113 | BCS, M | Mean: 144 (n/a) | 6 (2–40) | 51 (19–89) |
| Choi 201816 | Multi-centre, retrospective cohort | Korea | 127 | 235 | BCS, M | 60 (24–372) | 6 (0–38) | Median: 43 (13–75) |
| Sevinc 201817 | Single-centre, retrospective cohort | Turkey | 14 | 0 | BCS | 133 (36–240) | 2 (1–4) | 51 (n/a) |
| Ganesh 201818 | Single-centre, retrospective cohort | Canada | 17 | 53 | BCS, M | Bor: 66 (1–130) Mal: 50 (2–131) |
n/a | Bor: 49 (31–70) Mal: 50 (24–88) |
| Borhani-Khomani 201619 | Multi-centre, retrospective cohort | Denmark | 89 | 0 | LE, WLE, M | Mean: 84 (1–180) | 3 (1–20) | 44 (18–85) |
| Onkendi 201420 | Single-centre, retrospective cohort | USA | 15 | 52 | WLE, M | 120 (12–408) | 8 (n/a) | 47 (14–86) |
| Lin 201321 | Single-centre, retrospective cohort | Taiwan | 13 | 12 | M, PM | n/a | n/a | n/a |
| Abdalla 200622 | Single-centre, retrospective cohort | Cairo | 27 | 21 | LE, WLE, M | n/a | n/a | n/a |
| Asoglu 200423 | Single-centre, retrospective cohort | USA | 3 | 31 | WLE, M | n/a | n/a | n/a |
| Kapiris 200124 | Single-centre, retrospective cohort | UK | 0 | 48 | LE, WLE, M | 108 (5–336) | 8 (2–20) | 47 (21–85) |
BCS, breast conserving surgery; Bor, Borderline phyllodes tumour; LE, local excision; M, mastectomy; Mal, Malignant phyllodes tumour; n/a, data not available; PM, partial mastectomy; PT, phyllodes tumour; WLE, wide local excision.